As European markets experience a positive uptick with the pan-European STOXX Europe 600 Index rising 2.77% amid easing trade tensions, investors are keenly observing opportunities to strengthen their portfolios. In such an environment, dividend stocks can offer a reliable income stream and potential for growth, making them attractive options for those looking to enhance their investment strategies in the current market landscape.
Name | Dividend Yield | Dividend Rating |
Julius Bär Gruppe (SWX:BAER) | 4.88% | ★★★★★★ |
Zurich Insurance Group (SWX:ZURN) | 4.39% | ★★★★★★ |
Bredband2 i Skandinavien (OM:BRE2) | 4.61% | ★★★★★★ |
OVB Holding (XTRA:O4B) | 4.42% | ★★★★★★ |
S.N. Nuclearelectrica (BVB:SNN) | 9.22% | ★★★★★★ |
HEXPOL (OM:HPOL B) | 5.02% | ★★★★★★ |
Deutsche Post (XTRA:DHL) | 4.93% | ★★★★★★ |
Cembra Money Bank (SWX:CMBN) | 4.27% | ★★★★★★ |
Rubis (ENXTPA:RUI) | 7.11% | ★★★★★★ |
Banque Cantonale Vaudoise (SWX:BCVN) | 4.34% | ★★★★★★ |
Click here to see the full list of 234 stocks from our Top European Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Construcciones y Auxiliar de Ferrocarriles, S.A. is a company specializing in the design, manufacture, and maintenance of railway vehicles and equipment, with a market cap of approximately €1.47 billion.
Operations: Construcciones y Auxiliar de Ferrocarriles, S.A. generates revenue primarily from its Railway segment, including wheel sets and components, amounting to €3.29 billion and from its Buses segment contributing €926.87 million.
Dividend Yield: 3.1%
Construcciones y Auxiliar de Ferrocarriles (CAF) offers a mixed picture for dividend investors. While the company trades at 43.3% below its estimated fair value, providing potential capital appreciation, its dividend yield of 3.12% is lower than the Spanish market's top tier. Despite a well-covered payout ratio of 44.4%, CAF's dividends have been volatile over the past decade, lacking reliability and stability even as earnings and sales show growth with EUR 4.22 billion in sales for 2024.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Clínica Baviera, S.A. is a medical company that operates a network of ophthalmology clinics across Spain and Europe, with a market cap of €575.76 million.
Operations: Clínica Baviera, S.A. generates its revenue primarily from its ophthalmology clinics, with a total of €265.72 million.
Dividend Yield: 4.4%
Clínica Baviera's dividend profile shows both strengths and weaknesses for investors. While dividends are covered by earnings (66.6% payout ratio) and cash flows (69.3% cash payout ratio), their history is marked by volatility, with unstable payments over the past decade. Despite trading 26.3% below fair value, its 4.36% yield falls short of Spain's top-tier payers. Recent financial results highlight growth, with sales rising to €265.72 million and net income reaching €40.21 million in 2024.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Betsson AB (publ) operates and manages an online gaming business across various regions including the Nordic countries, Latin America, Western Europe, Central and Eastern Europe, Central Asia, and internationally with a market cap of SEK23.40 billion.
Operations: Betsson AB's revenue primarily comes from its operations in online gaming across diverse international markets.
Dividend Yield: 4.2%
Betsson's dividend profile offers a mixed view. While the company has proposed an ordinary dividend of €0.657 per share and a special dividend of €0.10, its history shows volatility with unreliable payments over the past decade. However, dividends are well covered by earnings (49.8% payout ratio) and cash flows (34.8% cash payout ratio). Recent Q1 2025 results showed growth, with sales at €293.7 million and net income at €48.2 million, supporting potential future payouts amidst ongoing M&A strategies.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:CAF BME:CBAV and OM:BETS B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。